Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
AdVac tuberculosis vaccine (AERAS-402/Crucell Ad35)
print preview
bookmark
share with colleague
General Information
Company
Johnson & Johnson
Description
Tuberculosis vaccine based on adenovirus serotype 35
Molecular Target
Not applicable
Mechanism of Action
Vaccine
Latest Stage of Development
Phase II
Indication
Tuberculosis
Partner
Aeras Global TB Vaccine Foundation
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information